Bayoglu, I. V. Et Al. 2015. Comparison of first-line bevacizumab in combination with mFOLFOX6 or XELOX in metastatic colorectal cancer. JOURNAL OF BUON , vol.20 , 460-467.

Bayoglu, I. V., Yildiz, I., Varol, U., Cokmert, S., Kucukzeybek, Y., Alacacioglu, A., ... Demir, L.(2015). Comparison of first-line bevacizumab in combination with mFOLFOX6 or XELOX in metastatic colorectal cancer. JOURNAL OF BUON , vol.20, 460-467.

Bayoglu, Ibrahim Et Al. "Comparison of first-line bevacizumab in combination with mFOLFOX6 or XELOX in metastatic colorectal cancer," JOURNAL OF BUON , vol.20, 460-467, 2015

Bayoglu, Ibrahim V. Et Al. "Comparison of first-line bevacizumab in combination with mFOLFOX6 or XELOX in metastatic colorectal cancer." JOURNAL OF BUON , vol.20, pp.460-467, 2015

Bayoglu, I. V. Et Al. (2015) . "Comparison of first-line bevacizumab in combination with mFOLFOX6 or XELOX in metastatic colorectal cancer." JOURNAL OF BUON , vol.20, pp.460-467.

@article{article, author={Ibrahim Vedat Bayoglu Et Al. }, title={Comparison of first-line bevacizumab in combination with mFOLFOX6 or XELOX in metastatic colorectal cancer}, journal={JOURNAL OF BUON}, year=2015, pages={460-467} }